| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5K | — | +0.0% |
| Cost of Revenue | $717K | +200.0% | +150.7% |
| Gross Profit | -$717K | -200.0% | -155.6% |
| R&D Expense | $344K | -1.8% | +2225.1% |
| SG&A Expense | $2.5M | +106.2% | +74.9% |
| Operating Income | -$3.5M | -97.6% | -83.5% |
| Pre-tax Income | -$2.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.3M | +41.5% | +166.0% |
| Short-term Investments | $4.9M | +48.3% | -69.7% |
| Current Assets | $13.8M | +56.7% | -58.5% |
| Total Assets | $15.7M | +70.9% | -56.3% |
| Current Liabilities | $1.9M | -74.8% | -62.4% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.2M | — | — |
| Capital Expenditures | $163K | — | — |
| Investing Cash Flow | -$2.3M | — | — |
| Financing Cash Flow | -$464K | — | — |
| Free Cash Flow | $1.0M | — | — |
| +80.5% |
| -601.0% |
| Net Income | -$2.8M | +80.5% | -601.0% |
| EPS (Basic) | -$3.84 | +87.1% | -1436.0% |
| EPS (Diluted) | -$3.84 | +87.1% | -1436.0% |
| $2.0M |
| -90.8% |
| -85.4% |
| Stockholders' Equity | $8.3M | +163.6% | -27.3% |